Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare Biotechnology

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Private placement

<< Previous

Bullboard Posts

Next >>

Comment by JMark80on Sep 16, 2020 2:14pm

117 Views

Post# 31568277

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Private placement

Radikal1 wrote:

Scotty wrote: You didn't answer the question.

I answered all your questions.

Why was the decision to let KLY default and not try to salvage something from it's multi-million dollar investment a decision that shouldn't reflect poorly on KLY?

All you said was CBD market conditions weren't favorable. Fine, a bad deal is better than none. Now we're just out that money and the company is a fiscal disaster.

But like I said, I'm sure that was the point. Either that or GROSS incompetence.

That's the first time you asked that question so, I will answer it.

They owed Talent money and so in effect, they sold GVHD for what they owed which was three million I do believe. As you said, a bad deal is better than none.

As for incompetence is every CEO who's companies lost tens of billions of dollars in the CBD crash also incompetent? If so, why are the majoirty of the still in those positions? Why didn't they see this downturn coming?